migvax / Covid-19 Vaccine Development by Migvax, MIGAL

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.migvax.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change

Meta Tags

Title	Covid-19 Vaccine Development by Migvax, MIGAL
Description	MigVax’s MigVax, a SPV by MIGAL is developing a vaccine for COVID-19, Coronavirus in
Keywords	N/A

Server Information

WebSite	migvax.com
Host IP	185.230.63.171
Location	-

Related Websites

                        Site
                        Rank
                    

More to Explore

migvax.com Valuation

US$2,188,224

Last updated: 2023-05-03 11:27:12

migvax.com has Semrush global rank of 4,836,938. migvax.com has an estimated worth of US$ 2,188,224, based on its estimated Ads revenue. migvax.com receives approximately 252,488 unique visitors each day. Its web server is located in -, with IP address 185.230.63.171. According to SiteAdvisor, migvax.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$2,188,224
Daily Ads Revenue	US$2,020
Monthly Ads Revenue	US$60,597
Yearly Ads Revenue	US$727,164
Daily Unique Visitors	16,833
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
migvax.com.	A	3599	IP: 185.230.63.171
migvax.com.	A	3599	IP: 185.230.63.186
migvax.com.	A	3599	IP: 185.230.63.107
migvax.com.	NS	86400	NS Record: ns14.wixdns.net.
migvax.com.	NS	86400	NS Record: ns15.wixdns.net.
migvax.com.	MX	3600	MX Record: 10 migvax-com.mail.protection.outlook.com.
migvax.com.	TXT	3600	TXT Record: MS=ms78320010
migvax.com.	TXT	3600	TXT Record: v=spf1 include:spf.protection.outlook.com -all

HtmlToTextCheckTime:2023-05-03 11:27:12

top of page Home The Science About MigVax Ltd. Management Researchers & Consultants News Contact Invest via OurCrowd MigVax’s Vaccine MigVax’s corona subunit vaccine Advantages of MigVax’s COVID-19 Subunit vaccine Platform technology Ease of switching Oral administration Triple-arm immunity Safety Efficient and cost-effective large-scale manufacturing MigVax-101 utilizes a chimeric protein to generate three kinds of simultaneous immunological responses: mucosal, blood-based, and cell-mediated immunity. This triple-armed approach provides comprehensive protection against infection by activating all arms of the immune system, allowing for the effective eradication of the invading virus. Its epitopes were designed using computational chemistry of immunogenic epitopes in IBV, MERS, SARS-COV and SAS-COV-2, focusing on neutralizing antibodies and promoting an immune response. Heterologous Boost Humoral immunity: Following two injected priming doses, Oral or injected vaccines are

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Mon, 25 Oct 2021 17:52:09 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.migvax.com/
strict-transport-security: max-age=120
x-wix-request-id: 1635184329.4153364365884618453
Age: 0
Server-Timing: cache;desc=miss, varnish;desc=miss, dc;desc=42
X-Seen-By: jeslxIFvDH4ulYwNNi+3Muwfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVgjB5iMgVduhJkO1xgMq9zO,m0j2EEknGIVUW/liY8BLLkiHzpTYSDRA7u88Ic3Fde7F+NHRbelhY0dsZwjDYnLI,2d58ifebGbosy5xc+FRalpwHz/LkgdlCo/BNCRRGcop1zKUhm3RNq8Kev+fV4qkyzN02lDM8MZw+Nunb8FObAw==,2UNV7KOq4oGjA5+PKsX47DqQgZ4euQCNWDy58PBtjlYfbJaKSXYQ/lskq2jK6SGP,YO37Gu9ywAGROWP0rn2IfgW5PRv7IKD225xALAZbAmk=,qJS91GsscGZlb16v+8nwmCCFP6xOEPOh4DarEVvdlxNGp/J3MBzgzU8QHrQuh4zQ,UvY1uiXtmgas6aI2l+unv4ev8DMUau+zzcyvLHz8aymvHt1QAdCI2rMofBwuIOZcVnd8Z4jLK9R467MyhrzM6w==
Cache-Control: no-cache
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Mon, 25 Oct 2021 17:52:09 GMT
content-type: text/html; charset=UTF-8
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
x-wix-request-id: 1635184329.56167015948417713
content-language: en
strict-transport-security: max-age=120
age: 0
x-seen-by: GXNXSWFXisshliUcwO20NXdyD4zpCpFzpCPkLds0yMd69Yfwh0zr6UUMS+tcD/r3,qquldgcFrj2n046g4RNSVI5y0OKACGwHEq+Bmxf53RlYgeUJqUXtid+86vZww+nL,2d58ifebGbosy5xc+FRalhdicx80VOyqJHROZZQWQUhnUOAB/KdCbD8S+mG7jrh4Sf524lPwTgDbn82fURSkbmrGoQYNt6gnPAu2JbQpk4w=,2UNV7KOq4oGjA5+PKsX47BKn5Yg4ON9Aa7djl3ltpSdYgeUJqUXtid+86vZww+nL,YO37Gu9ywAGROWP0rn2IfgW5PRv7IKD225xALAZbAmk=,UvY1uiXtmgas6aI2l+unv3OTp703XQYtIoJ/ca4v755ZoHjQgb5ategVQRAis2ZOWIHlCalF7YnfvOr2cMPpyw==,dvEkI3CoQ26/kOBf/eu3DOD58fvxgAMrqUbe2UVKjyEaWyug/ZdHQ36uOAkr89T0,qQbTLsvPZVUXp9HeAm/lzAFBY+irFtzfdduRQdjD05NGp/J3MBzgzU8QHrQuh4zQ,LoUK8/saGAmOxZWtpubo2iTOnK3GmbK6QcBXwd5Fv/oc74f38NrjaRRoWTWpPVw3wDzIvzKp6uG5DzoYKWT7fw==,qQbTLsvPZVUXp9HeAm/lzAFBY+irFtzfdduRQdjD05NGp/J3MBzgzU8QHrQuh4zQ,JLaio/7uvfP647F5CQsGZVM1hJ/vWAboXcI15hFqOw9Gp/J3MBzgzU8QHrQuh4zQ,/a5ccLSK1HEmwPNg/x6OuntjqKv6IMr0lqdQ/qxGlZXCceNgH8pfaioxo7SODAmdjucOxwwpyxAUVrh5HhR3WA==
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
set-cookie: ssr-caching=cache#desc=miss#varnish=miss#dc#desc=usc1_g; Max-Age=20; Expires=Mon, 25 Oct 2021 17:52:29 GMT
server-timing: cache;desc=miss, varnish;desc=miss, dc;desc=usc1_g
x-content-type-options: nosniff
server: Pepyaka/1.19.10
via: 1.1 google
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"

migvax.com Whois Information

Domain Name: MIGVAX.COM
Registry Domain ID: 2510806695_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2020-04-20T08:39:21Z
Creation Date: 2020-04-03T20:12:49Z
Registry Expiry Date: 2022-04-03T20:12:49Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS14.WIXDNS.NET
Name Server: NS15.WIXDNS.NET
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-13T20:31:24Z <<<

migvax.com valuation and analysis